Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2023-02-15 06:39 am Unchanged |
2022-12-31 | 13G | scPharmaceuticals Inc. SCPH |
HIRSCHMAN ORIN | 2,550,234 7.500% |
0 (Unchanged) |
Filing History |
| 2023-02-14 4:04 pm Sale |
2022-12-31 | 13G | scPharmaceuticals Inc. SCPH |
5AM Ventures IV L.P. | 2,734,852 8.000% |
-1,096,622 (-28.62%) |
Filing History |
| 2023-02-14 1:25 pm Purchase |
2022-12-31 | 13G | scPharmaceuticals Inc. SCPH |
Armistice Capital, LLC | 2,148,000 6.310% |
2,148,000 (New Position) |
Filing History |
| 2022-11-29 4:27 pm Purchase |
2022-11-25 | 13D | scPharmaceuticals Inc. SCPH |
ORBIMED ADVISORS LLC | 5,559,528 16.300% |
762,380 (+15.89%) |
Filing History |
| 2022-11-25 06:04 am Purchase |
2022-11-22 | 13G | scPharmaceuticals Inc. SCPH |
HIRSCHMAN ORIN | 2,550,234 7.500% |
2,550,234 (New Position) |
Filing History |
| 2022-08-15 5:19 pm Sale |
2022-08-15 | 13G | scPharmaceuticals Inc. SCPH |
RA Capital Management, L.P. | 0 0.000% |
-2,691,770 (Position Closed) |
Filing History |
| 2022-02-18 4:36 pm Sale |
2021-12-31 | 13G | scPharmaceuticals Inc. SCPH |
RA Capital Management, L.P. | 2,691,770 9.840% |
-4,000,000 (-59.77%) |
Filing History |
| 2022-02-14 4:35 pm Sale |
2021-12-31 | 13G | scPharmaceuticals Inc. SCPH |
Ikarian Capital LLC | 901,362 3.300% |
-564,785 (-38.52%) |
Filing History |
| 2022-02-14 4:11 pm Purchase |
2021-12-31 | 13G | scPharmaceuticals Inc. SCPH |
RA Capital Management, L.P. | 6,691,770 9.840% |
3,172,772 (+90.16%) |
Filing History |
| 2021-02-16 4:39 pm Purchase |
2020-12-31 | 13G | scPharmaceuticals Inc. SCPH |
RA Capital Management, L.P. | 3,518,998 12.900% |
271,993 (+8.38%) |
Filing History |
| 2021-02-16 06:30 am Purchase |
2020-12-31 | 13G | scPharmaceuticals Inc. SCPH |
5AM Ventures IV L.P. | 3,831,474 14.000% |
578,034 (+17.77%) |
Filing History |
| 2021-02-12 4:35 pm Purchase |
2020-12-31 | 13G | scPharmaceuticals Inc. SCPH |
Ikarian Capital LLC | 1,466,147 5.400% |
392,500 (+36.56%) |
Filing History |
| 2020-06-03 08:56 am Unchanged |
2020-05-26 | 13D | scPharmaceuticals Inc. SCPH |
SUN PHARMACEUTICAL INDUSTRIES LTD | 2,167,679 8.100% |
0 (Unchanged) |
Filing History |
| 2020-05-26 4:40 pm Purchase |
2020-05-21 | 13D | scPharmaceuticals Inc. SCPH |
ORBIMED ADVISORS LLC | 4,797,148 17.900% |
1,387,283 (+40.68%) |
Filing History |